Eli Lilly Goes On A $3.83 Billion Acquisition Spree. Where's It Pushing Now?
Eli Lilly acquired three infectious diseases companies for up to $3.83 billion. Lilly stock ticked higher in response.
Open original sourceLoading market dashboard
Eli Lilly acquired three infectious diseases companies for up to $3.83 billion. Lilly stock ticked higher in response.
Open original source